this should have a market cap of 100 million +, page-115

Cheers Chuck. Buy side looks interesting today. Price is hopping around a bit (no punn intended) but the depth on the buy side is very strong ..... 2.5mil in top two positions. I see somebody turned a bot on also just to muddy the waters.

We know from recent announcement that the company is seeking to commercialise via a partner deal, or licensing the IP. Their funding announcement in Jan coupled with this current trial leave me witht he feeling that they hope to pull off something this year.

I suspect that 12 weeks of dosing in this new trial will produce the best results yet. Hopefully is shows 100% for both G1 and G3. If so that should position them very well. Will be very interesting to see what happens.